198 related articles for article (PubMed ID: 18310079)
1. The role of RIP2 in p38 MAPK activation in the stressed heart.
Jacquet S; Nishino Y; Kumphune S; Sicard P; Clark JE; Kobayashi KS; Flavell RA; Eickhoff J; Cotten M; Marber MS
J Biol Chem; 2008 May; 283(18):11964-71. PubMed ID: 18310079
[TBL] [Abstract][Full Text] [Related]
2. Activation of p38 mitogen-activated protein kinase contributes to the early cardiodepressant action of tumor necrosis factor.
Bellahcene M; Jacquet S; Cao XB; Tanno M; Haworth RS; Layland J; Kabir AM; Gaestel M; Davis RJ; Flavell RA; Shah AM; Avkiran M; Marber MS
J Am Coll Cardiol; 2006 Aug; 48(3):545-55. PubMed ID: 16875982
[TBL] [Abstract][Full Text] [Related]
3. Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia.
Tanno M; Bassi R; Gorog DA; Saurin AT; Jiang J; Heads RJ; Martin JL; Davis RJ; Flavell RA; Marber MS
Circ Res; 2003 Aug; 93(3):254-61. PubMed ID: 12829618
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological postconditioning effect of muramyl dipeptide is mediated through RIP2 and TAK1.
Sicard P; Jacquet S; Kobayashi KS; Flavell RA; Marber MS
Cardiovasc Res; 2009 Jul; 83(2):277-84. PubMed ID: 19213760
[TBL] [Abstract][Full Text] [Related]
5. Role of p38-mitogen-activated protein kinase in ischaemic preconditioning in rat heart.
Bell JR; Eaton P; Shattock MJ
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):126-34. PubMed ID: 17892505
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide.
Windheim M; Lang C; Peggie M; Plater LA; Cohen P
Biochem J; 2007 Jun; 404(2):179-90. PubMed ID: 17348859
[TBL] [Abstract][Full Text] [Related]
7. A chemical genetic approach reveals that p38alpha MAPK activation by diphosphorylation aggravates myocardial infarction and is prevented by the direct binding of SB203580.
Kumphune S; Bassi R; Jacquet S; Sicard P; Clark JE; Verma S; Avkiran M; O'Keefe SJ; Marber MS
J Biol Chem; 2010 Jan; 285(5):2968-75. PubMed ID: 19996096
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A
Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of RIP2/RIck/CARDIAK activity by pyridinyl imidazole inhibitors of p38 MAPK.
Argast GM; Fausto N; Campbell JS
Mol Cell Biochem; 2005 Jan; 268(1-2):129-40. PubMed ID: 15724446
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of receptor-interacting serine/threonine kinase 2 (RIP2) of the goldfish (Carassius auratus L.).
Xie J; Belosevic M
Dev Comp Immunol; 2015 Jan; 48(1):76-85. PubMed ID: 25242011
[TBL] [Abstract][Full Text] [Related]
11. AMP-activated protein kinase activates p38 mitogen-activated protein kinase by increasing recruitment of p38 MAPK to TAB1 in the ischemic heart.
Li J; Miller EJ; Ninomiya-Tsuji J; Russell RR; Young LH
Circ Res; 2005 Oct; 97(9):872-9. PubMed ID: 16179588
[TBL] [Abstract][Full Text] [Related]
12. Stem cell factor/c-kit signaling mediated cardiac stem cell migration via activation of p38 MAPK.
Kuang D; Zhao X; Xiao G; Ni J; Feng Y; Wu R; Wang G
Basic Res Cardiol; 2008 May; 103(3):265-73. PubMed ID: 18087667
[TBL] [Abstract][Full Text] [Related]
13. MAPKAPK-2 modulates p38-MAPK localization and small heat shock protein phosphorylation but does not mediate the injury associated with p38-MAPK activation during myocardial ischemia.
Gorog DA; Jabr RI; Tanno M; Sarafraz N; Clark JE; Fisher SG; Cao XB; Bellahcene M; Dighe K; Kabir AM; Quinlan RA; Kato K; Gaestel M; Marber MS; Heads RJ
Cell Stress Chaperones; 2009 Sep; 14(5):477-89. PubMed ID: 19214782
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of p38 MAPK activation protects cardiac mitochondria from ischemia/reperfusion injury.
Kumphune S; Surinkaew S; Chattipakorn SC; Chattipakorn N
Pharm Biol; 2015; 53(12):1831-41. PubMed ID: 25880145
[TBL] [Abstract][Full Text] [Related]
15. Hyperglycemia suppresses cardiac stem cell homing to peri-infarcted myocardium via regulation of ERK1/2 and p38 MAPK activities.
She T; Wang X; Gan Y; Kuang D; Yue J; Ni J; Zhao X; Wang G
Int J Mol Med; 2012 Dec; 30(6):1313-20. PubMed ID: 22965067
[TBL] [Abstract][Full Text] [Related]
16. p38 mitogen-activated protein kinase mediates adenosine-induced alterations in myocardial glucose utilization via 5'-AMP-activated protein kinase.
Jaswal JS; Gandhi M; Finegan BA; Dyck JR; Clanachan AS
Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1978-85. PubMed ID: 17172269
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of p38 MAPK activity fails to attenuate contractile dysfunction in a mouse model of low-flow ischemia.
Gorog DA; Tanno M; Cao X; Bellahcene M; Bassi R; Kabir AM; Dighe K; Quinlan RA; Marber MS
Cardiovasc Res; 2004 Jan; 61(1):123-31. PubMed ID: 14732209
[TBL] [Abstract][Full Text] [Related]
18. Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK.
Nakano A; Baines CP; Kim SO; Pelech SL; Downey JM; Cohen MV; Critz SD
Circ Res; 2000 Feb; 86(2):144-51. PubMed ID: 10666409
[TBL] [Abstract][Full Text] [Related]
19. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury.
Chai W; Wu Y; Li G; Cao W; Yang Z; Liu Z
Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E183-9. PubMed ID: 18003719
[TBL] [Abstract][Full Text] [Related]
20. Coronary microembolization induced myocardial contractile dysfunction and tumor necrosis factor-α mRNA expression partly inhibited by SB203580 through a p38 mitogen-activated protein kinase pathway.
Li L; Qu N; Li DH; Wen WM; Huang WQ
Chin Med J (Engl); 2011 Jan; 124(1):100-5. PubMed ID: 21362316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
